001570:KRXKumyang Co., Ltd. Analysis

Kumyang Co., Ltd. is facing a severe earnings crunch, with revenue plunging 50.6% year‑over‑year and operating margins in the -45.7% range, while net profit margins sit at a distressing -73.9%. The balance sheet is heavily leveraged, evidenced by a debt‑to‑equity ratio of 71.1 and a price‑to‑sales multiple near 7.4, yet the company carries no dividend and reports zero EPS. Technically, the stock is stuck at a flat price of 9,900 KRW, with the 20‑day, 50‑day and 200‑day SMAs all converging at this level, an RSI of 100 indicating extreme overbought conditions, and a bearish trend direction despite negligible volatility.
Liquidity appears thin, with no reported trading volume, and the sector—specialty chemicals—carries moderate regulatory exposure. Combined with an elevated overall risk profile, the outlook remains bleak unless a dramatic operational turnaround or deleveraging occurs.